$CUTR
CUTERA INC Stock $cutr

$cutr Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024022635 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$34.38M	$38.79M	$49.54M
YoY Change	-43.84%	-29.46%	-26.45%
Cost Of Revenue	$26.73M	$26.37M	$43.30M
YoY Change	-19.39%	-12.28%	51.37%
Gross Profit	$7.644M	$12.42M	$6.241M
YoY Change	-72.75%	-50.18%	-83.89%
Gross Profit Margin	22.24%	32.01%	12.6%
Selling, General & Admin	$24.99M	$36.56M	$45.99M
YoY Change	-51.77%	-13.02%	18.3%
% of Gross Profit	326.86%	294.37%	736.95%
Research & Development	$4.463M	$5.001M	$4.564M
YoY Change	-22.84%	-22.68%	-15.61%
% of Gross Profit	58.39%	40.27%	73.13%
Depreciation & Amortization	$1.804M	$1.991M	$3.350M
YoY Change	-54.8%	-44.49%	229.08%
% of Gross Profit	23.6%	16.03%	53.68%
Operating Expenses	$29.45M	$31.85M	$50.56M
YoY Change	-48.86%	-34.32%	14.16%
Operating Profit	-$21.80M	-$19.43M	-$44.32M
YoY Change	-26.16%	-17.55%	700.51%
Interest Expense	$1.025M	$1.455M	-$1.183M
YoY Change	-52.96%	-41.31%	158.86%
% of Operating Profit
Other Income/Expense, Net	-$2.896M	-$3.371M	$1.038M
YoY Change	61.88%	186.89%	-200.68%
Pretax Income	-$24.70M	-$22.80M	-$44.46M
YoY Change	-21.13%	-7.84%	532.99%
Income Tax	-$19.00K	-$25.00K	$769.0K
% Of Pretax Income
Net Earnings	-$24.68M	-$22.80M	-$45.23M
YoY Change	-22.0%	-8.86%	480.77%
Net Earnings / Revenue	-71.8%	-58.77%	-91.3%
Basic Earnings Per Share	-$1.23	-$1.14	-$2.87
Diluted Earnings Per Share	-$1.23	-$1.14	-$2.27
COMMON SHARES
Basic Shares Outstanding	20.07M shares	19.96M shares
Diluted Shares Outstanding	20.09M shares	19.99M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$83.12M	$105.4M	$143.6M
YoY Change	-62.66%	-60.6%	-54.74%
Cash & Equivalents	$83.12M	$105.4M	$143.6M
Short-Term Investments			$0.00
Other Short-Term Assets	$380.0K	$365.0K	$19.63M
YoY Change	-98.52%	5114.29%	-20.65%
Inventory	$80.35M	$73.47M	$61.73M
Prepaid Expenses	$4.559M	$2.933M	$3.819M
Receivables	$34.55M	$37.02M	$43.37M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$211.0M	$235.2M	$268.3M
YoY Change	-42.97%	-43.79%	-40.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$39.53M	$44.00M	$47.33M
YoY Change	-48.59%	-32.39%	-11.03%
Goodwill	$1.339M	$1.339M	$1.339M
YoY Change	0.0%	0.0%	3.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.916M	$10.31M	$38.17M
YoY Change	-41.0%	-28.1%	150.92%
Total Long-Term Assets	$65.31M	$76.77M	$86.83M
YoY Change	-30.43%	-5.62%	24.5%
TOTAL ASSETS
Total Short-Term Assets	$211.0M	$235.2M	$268.3M
Total Long-Term Assets	$65.31M	$76.77M	$86.83M
Total Assets	$276.3M	$312.0M	$355.2M
YoY Change	-40.43%	-37.58%	-31.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.62M	$13.32M	$19.83M
YoY Change	-48.55%	-62.14%	-41.22%
Accrued Expenses	$30.36M	$47.12M	$54.37M
YoY Change	-43.54%	-19.67%	-9.78%
Deferred Revenue	$8.798M	$9.038M	$10.42M
YoY Change			-11.98%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$714.0K	$744.0K	$825.0K
YoY Change	54.21%	55.0%	70.1%
Total Short-Term Liabilities	$60.15M	$72.70M	$84.62M
YoY Change	-41.63%	-33.17%	-20.05%
LONG-TERM LIABILITIES
Long-Term Debt	$420.6M	$420.2M	$418.7M
YoY Change	0.59%	0.59%	0.54%
Other Long-Term Liabilities	$1.242M	$1.122M	$11.68M
YoY Change	116.0%	57.81%	-15.8%
Total Long-Term Liabilities	$1.242M	$1.122M	$430.4M
YoY Change	116.0%	57.81%	0.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$60.15M	$72.70M	$84.62M
Total Long-Term Liabilities	$1.242M	$1.122M	$430.4M
Total Liabilities	$492.0M	$504.6M	$515.0M
YoY Change	-7.69%	-6.36%	-3.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$350.8M	-$326.1M	-$303.3M
YoY Change	77.92%	97.02%	115.88%
Common Stock	$135.1M	$133.6M	$131.5M
YoY Change	5.55%	5.56%	4.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$215.7M	-$192.6M	-$159.8M
YoY Change
Total Liabilities & Shareholders Equity	$276.3M	$312.0M	$355.2M
YoY Change	-40.43%	-37.58%	-31.83%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$24.68M	-$22.80M	-$45.23M
YoY Change	-22.0%	-8.86%	480.77%
Depreciation, Depletion And Amortization	$1.804M	$1.991M	$3.350M
YoY Change	-54.8%	-44.49%	229.08%
Cash From Operating Activities	-$20.24M	-$37.63M	-$33.77M
YoY Change	-35.25%	1.53%	98.35%
INVESTING ACTIVITIES
Capital Expenditures	$882.0K	$335.0K	$2.599M
YoY Change	-94.02%	-97.0%	-69.75%
Acquisitions
YoY Change
Other Investing Activities	$6.000K	$57.00K	$0.00
YoY Change	-99.99%	-99.92%	-100.0%
Cash From Investing Activities	-$876.0K	-$278.0K	-$2.599M
YoY Change	-101.94%	-100.46%	-110.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-13.00K	-$260.0K	-232.0K
YoY Change	-91.5%	-89.22%	-100.25%
NET CHANGE
Cash From Operating Activities	-20.24M	-$37.63M	-33.77M
Cash From Investing Activities	-876.0K	-$278.0K	-2.599M
Cash From Financing Activities	-13.00K	-$260.0K	-232.0K
Net Change In Cash	-21.13M	-$38.17M	-36.60M
YoY Change	-252.85%	-282.59%	-136.59%
FREE CASH FLOW
Cash From Operating Activities	-$20.24M	-$37.63M	-$33.77M
Capital Expenditures	$882.0K	$335.0K	$2.599M
Free Cash Flow	-$21.13M	-$37.97M	-$36.37M
YoY Change	-54.09%	-21.26%	41.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19960622	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19960622	shares
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2024Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1	us-gaap	Goodwill Goodwill	1339000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1339000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12034000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10055000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10313000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11575000	usd
CY2024Q1	us-gaap	Assets Assets	311992000	usd
CY2023Q4	us-gaap	Assets Assets	346291000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	13316000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19829000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	47119000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	55055000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3231000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2441000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9038000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10422000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	72704000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87747000	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1417000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1494000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10046000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8887000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	9859000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	10430000	usd
CY2024Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	419266000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	418695000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1122000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1298000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	504555000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	518121000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20067941	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20067941	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	133541000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	131496000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-326124000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-303346000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-192563000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-171830000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	311992000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	346291000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	38793000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54526000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	26374000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32894000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	12419000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	21632000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23677000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29512000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5001000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6468000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12881000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12253000	usd
CY2024Q1	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	9708000	usd
CY2023Q1	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	31851000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	48233000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-19432000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-26601000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	571000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	552000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2939000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2939000	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1455000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2636000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1316000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-320000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3371000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1175000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22803000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27776000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	272000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-22778000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-28048000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.14
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.42
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.42
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19991000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19776000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19991000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19776000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-22778000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-28048000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	86000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	86000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22778000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27962000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-171830000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-64000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2109000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-22778000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-192563000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-15181000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	109000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-2397000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3386000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	86000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-42045000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-22778000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2109000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3386000	usd
CY2024Q1	cutr	Depreciation And Amortization Excluding Contract Acquisition Costs DepreciationAndAmortizationExcludingContractAcquisitionCosts	1991000	usd
CY2023Q1	cutr	Depreciation And Amortization Excluding Contract Acquisition Costs DepreciationAndAmortizationExcludingContractAcquisitionCosts	1409000	usd
CY2024Q1	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	1391000	usd
CY2023Q1	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	2178000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	571000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	552000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	623000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	34000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	45000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2181000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	225000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3921000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6410000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11461000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6163000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-560000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2053000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	240000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2011000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-6513000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1330000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7916000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1706000	usd
CY2024Q1	cutr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-30000	usd
CY2023Q1	cutr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-16000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1461000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	201000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37630000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37018000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	335000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10353000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	57000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	94154000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	23467000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-278000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	60334000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	109000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	64000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2397000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	196000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	124000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-260000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2412000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-38168000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	20904000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	143612000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146624000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105444000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	167528000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	33000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2749000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	57000	usd
CY2024Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	6894000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	817000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	778000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	804000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	483000	usd
CY2024Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	38	country
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-22800000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reclassified the interest expense portion previously recorded in interest income (expense), net to other income (expense), net on the condensed consolidated statement of operations. Corresponding reclassifications of prior period amounts have been made in the Company's condensed consolidated statement of operations to conform to the current period presentation. These reclassifications had no effect on the reported net loss.</span></div>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, fair value of investments, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived assets, implicit and incremental borrowing rates related to the Company’s leases, variables used in calculating the fair value of the Company's equity awards, expected achievement of performance-based vesting criteria and management performance bonuses, assumptions used in operating and sales-type lease classifications, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable considerations, contingent liabilities, recoverability of deferred tax assets, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div>
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distribution of Third-Party Products </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generated revenue from the distribution of skincare products, which were manufactured by ZO Skin Health, Inc. (“ZO”), and sold in the Japanese market. In the three months ended March 31, 2024, and 2023, revenue from the distribution of skincare products was $4.2 million and $8.1 million, respectively, representing 11% and 15% of the Company’s consolidated revenue, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2024, the Company and its Japanese subsidiary, Cutera KK, entered into a termination agreement (the “Termination Agreement”) with ZO USA and its Japanese subsidiary, ZO Skin Health GK (“ZO Japan” and together with ZO USA and their affiliates, “ZO”), which, among other things, (i) terminates all agreements related to the distribution by the Company of ZO’s products in Japan effective immediately, (ii) provides for the orderly transition of the distribution of ZO products to ZO, (iii) transfers certain Company employees dedicated to the distribution of ZO products to ZO, (iv) transfers certain customer contracts related to ZO products from the Company to ZO and (v) transfers certain inventory and assets related to the distribution of ZO products from the Company to ZO. The Termination Agreement requires ZO to pay the Company $5.75 million within three business days of the execution of the Termination Agreement and make a second payment of $5.75 million, less any offsets under the Termination Agreement (including, but not limited to, 42.2% of the Company’s net revenue for sales of ZO products under the Distribution Agreement between January 1, 2024 and February 28, 2024), upon the earlier of (a) the completion the transition of regulatory and distribution activities such that ZO is able to fulfill product orders by customers in Japan, as determined by ZO and the Company, and (b) June 14, 2024. The Company received the first payment of $5.75 million on February 29, 2024, and received a second payment of $2.37 million on April 1, 2024, which was net of $1.6 million in amounts owed by Cutera. The In the three months ended March 31, 2024, the Company recorded the net gain of $9.7 million resulting from the early termination proceeds received and the transfer of certain assets and liabilities as gain on early termination of distribution agreement on the Company's condensed consolidated statement of operations.</span></div>The Company generates revenue from the distribution of the Secret systems, which are manufactured by ilooda Co. Ltd. (“ilooda”). The Company is the exclusive distributor for all systems sold in the United States, Canada, the United Kingdom; the exclusive distributor for certain systems in France, and Spain; and the non-exclusive distributor for systems sold in Austria and Germany. In the three months ended March 31, 2024, and 2023, revenue from the distribution of Secret products represented 6% and 4%, respectively, of the Company’s consolidated revenue. The Company‘s ilooda distribution agreement expires in June 30, 2026.
CY2024Q1	cutr	Termination Agreement Percent Net Revenue Reduction To Termination Fee Receivable TerminationAgreementPercentNetRevenueReductionToTerminationFeeReceivable	0.422
CY2024Q1	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	9700000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105400000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	143600000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	51870000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36970000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1978000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	889000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19621000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	24741000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	73469000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	62600000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	13700000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	13000000	usd
CY2024Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6884000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6307000	usd
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	6738000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	9501000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2933000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3819000	usd
CY2024Q1	cutr	Litigation Settlement Receivable Current LitigationSettlementReceivableCurrent	2374000	usd
CY2023Q4	cutr	Litigation Settlement Receivable Current LitigationSettlementReceivableCurrent	0	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	365000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	225000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19294000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19852000	usd
CY2024Q1	cutr	Inventory Raw Materials Noncurrent InventoryRawMaterialsNoncurrent	12864000	usd
CY2023Q4	cutr	Inventory Raw Materials Noncurrent InventoryRawMaterialsNoncurrent	8672000	usd
CY2024Q1	cutr	Inventory Work In Process Noncurrent InventoryWorkInProcessNoncurrent	1332000	usd
CY2023Q4	cutr	Inventory Work In Process Noncurrent InventoryWorkInProcessNoncurrent	2049000	usd
CY2024Q1	cutr	Inventory Finished Goods Noncurrent InventoryFinishedGoodsNoncurrent	6386000	usd
CY2023Q4	cutr	Inventory Finished Goods Noncurrent InventoryFinishedGoodsNoncurrent	5562000	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	20582000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	16283000	usd
CY2024Q1	cutr	Inventory Noncurrent Valuation Reserves InventoryNoncurrentValuationReserves	19000000	usd
CY2023Q4	cutr	Inventory Noncurrent Valuation Reserves InventoryNoncurrentValuationReserves	12800000	usd
CY2024Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	42888000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	47602000	usd
CY2024Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	10924000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	10327000	usd
CY2024Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	31964000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	37275000	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	14647000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	13949000	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6531000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6325000	usd
CY2024Q1	cutr	Accrued Inventory In Transit Current AccruedInventoryInTransitCurrent	5004000	usd
CY2023Q4	cutr	Accrued Inventory In Transit Current AccruedInventoryInTransitCurrent	5461000	usd
CY2024Q1	cutr	Sales And Marketing Accruals Current SalesAndMarketingAccrualsCurrent	4100000	usd
CY2023Q4	cutr	Sales And Marketing Accruals Current SalesAndMarketingAccrualsCurrent	4929000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	3465000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1304000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2472000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2593000	usd
CY2024Q1	cutr	Litigation Settlement Payable Current LitigationSettlementPayableCurrent	750000	usd
CY2023Q4	cutr	Litigation Settlement Payable Current LitigationSettlementPayableCurrent	8908000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10150000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11586000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	47119000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	55055000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2593000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3254000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1156000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1016000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1277000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1116000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2472000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3154000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11916000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13498000	usd
CY2024Q1	cutr	Contract With Customer Liability Increase Advance Payments Received ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived	3850000	usd
CY2023Q1	cutr	Contract With Customer Liability Increase Advance Payments Received ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived	6045000	usd
CY2024Q1	cutr	Contract With Customer Liability Decrease From Revenue Deferred ContractWithCustomerLiabilityDecreaseFromRevenueDeferred	572000	usd
CY2023Q1	cutr	Contract With Customer Liability Decrease From Revenue Deferred ContractWithCustomerLiabilityDecreaseFromRevenueDeferred	615000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4739000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5229000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10455000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13699000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.86
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	10500000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024Q1	cutr	Costs For Extended Service Contracts CostsForExtendedServiceContracts	1600000	usd
CY2023Q1	cutr	Costs For Extended Service Contracts CostsForExtendedServiceContracts	1600000	usd
CY2024Q1	cutr	Revenue From Contract With Customer Typical Payment Receipt Period Post Shipment RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment	P30D
CY2024Q1	cutr	Contract With Customer Liability Training Provided With Sale Of System Period ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod	P90D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3554537	shares
CY2024Q1	cutr	Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Additional Share Reserved ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalShareReserved	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	32396	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	43582	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2981015	shares
CY2024Q1	cutr	Share Based Payment Arrangement Shares Granted Tax Withholding Ratio ShareBasedPaymentArrangementSharesGrantedTaxWithholdingRatio	1.65
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1282240	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.97
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M15D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	520000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.11
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	43582	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	33.88
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1758658	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.89
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M13D
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2109000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3386000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22778000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28048000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19991000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19776000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19991000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19776000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.14
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.42
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.42
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21662000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18554000	shares
CY2024Q1	cutr	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	-100000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
CY2024Q1	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P5Y
CY2024Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12034000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10055000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2228000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2516000	usd
CY2024Q1	cutr	Lease Right Of Use Asset LeaseRightOfUseAsset	14262000	usd
CY2023Q4	cutr	Lease Right Of Use Asset LeaseRightOfUseAsset	12571000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3231000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2441000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10046000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8887000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	13277000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	11328000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	744000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	825000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	888000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1064000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1632000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1889000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	274000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	150000	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	42000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	20000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	969000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	891000	usd
CY2024Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	40000	usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	20000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	196000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	124000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	948000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	699000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2895000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3981000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4027000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3299000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	323000	usd
CY2024Q1	cutr	Lessee Operating Lease Liability To Be Paid Due After Year Four LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour	143000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14668000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1391000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	13277000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	731000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	697000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	424000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	16000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1868000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	236000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1632000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.057
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.095
CY2024Q1	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2024Q1	cutr	Lessor Duration Of Autorenewal Features LessorDurationOfAutorenewalFeatures	P1Y
CY2024Q1	cutr	Number Of Consecutive Lease Terms NumberOfConsecutiveLeaseTerms	2	lease_term
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	5615000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	2600000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	8215000	usd
CY2023Q1	us-gaap	Loss Contingency Patents Allegedly Infringed Number LossContingencyPatentsAllegedlyInfringedNumber	6	patent
CY2023Q1	us-gaap	Loss Contingency Patents Allegedly Infringed Number LossContingencyPatentsAllegedlyInfringedNumber	6	patent
CY2023Q1	us-gaap	Loss Contingency Patents Allegedly Infringed Number LossContingencyPatentsAllegedlyInfringedNumber	6	patent
CY2024Q1	us-gaap	Purchase Obligation PurchaseObligation	9700000	usd
CY2023Q4	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q4	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	38793000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54526000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	38793000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54526000	usd

Files In Submission

Name	View Source	Status
0001628280-24-022635-index-headers.html	Edgar Link	pending
0001628280-24-022635-index.html	Edgar Link	pending
0001628280-24-022635.txt	Edgar Link	pending
0001628280-24-022635-xbrl.zip	Edgar Link	pending
cutr-20240331.htm	Edgar Link	pending
cutr-20240331.xsd	Edgar Link	pending
cutr-20240331x10qexx311.htm	Edgar Link	pending
cutr-20240331x10qexx312.htm	Edgar Link	pending
cutr-20240331x10qexx321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
cutr-20240331_def.xml	Edgar Link	unprocessable
cutr-20240331_lab.xml	Edgar Link	unprocessable
cutr-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cutr-20240331_htm.xml	Edgar Link	completed
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cutr-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CUTR
CUTERA INC Stock $cutr

2024 Q2 Form 10-Q Financial Statement

#000162828024022635 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUTR CUTERA INC Stock $cutr

2024 Q2 Form 10-Q Financial Statement

#000162828024022635 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUTR
CUTERA INC Stock $cutr